Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 20th February 2017
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Researchers discover new antibiotic in African ant
petri dish
The new species is a member of the Streptomycin bacteria family.
Tests show antibiotic is highly-effective against MRSA

Researchers have discovered a new species of antibiotic, produced by the bacteria of an African ant, that is highly effective against MRSA.

The finding, published in the journal Chemical Science, was made by scientists at the University of East Anglia and the John Innes Centre.

The new species is a member of the Streptomycin bacteria family and was discovered on the African fungus-growing plant-ant, Tertraponera penzigi.

Tests show that the antibiotic is potent against antibiotic-resistant 'superbugs' such as methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococci (VRE).

Professor Wilkinson from the John Innes Centre commented: “Our finding highlights the importance of searching as-yet under-expired environments, which, when combined with recent advances in genome sequencing and editing, enables the discovery of new species making natural product antibiotics which could prove invaluable in the fight against AMR.”

Currently, nearly all of the antibiotics in use originate from a group of bacteria called actinomycetes. This bacteria was isolated from soil between 40 and 80 years ago, in what is known as the ‘golden age’ of antibiotic discovery.

Since then, inappropriate use of these antibiotics has led to widespread antimicrobial resistance where disease-causing bacteria have become resistant to some of these antibiotics.

“We have been exploring the chemical ecology of protective symbioses formed between antibiotic-producing bacteria and fungus-growing insects to better understand how these associations are formed and explore them as a new source of anti-infective drugs,” said Prof Matt Hutchings from the University of East Anglia.

“Kenyan plant-ants live in symbiosis with thorny acacia trees. They live and breed in domatia - which are hollowed out structures which the plant evolved to house them - and grow fungus in them for food. In return, they protect the plants from large herbivores including elephants, which won't eat plants covered in ants.”

The antibiotic has been named ‘streptomyces formicae,’ and the antibiotics formicamycins, after the latin formica, meaning ant.

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.